BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 31083446)

  • 21. Marine Natural Product Inhibitors of Neutrophil-Associated Inflammation.
    Chen CY; Tsai YF; Chang WY; Yang SC; Hwang TL
    Mar Drugs; 2016 Jul; 14(8):. PubMed ID: 27472345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immuno-Modulatory and Anti-Inflammatory Effects of Dihydrogracilin A, a Terpene Derived from the Marine Sponge Dendrilla membranosa.
    Ciaglia E; Malfitano AM; Laezza C; Fontana A; Nuzzo G; Cutignano A; Abate M; Pelin M; Sosa S; Bifulco M; Gazzerro P
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microalgae with Immunomodulatory Activities.
    Riccio G; Lauritano C
    Mar Drugs; 2019 Dec; 18(1):. PubMed ID: 31861368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent Discoveries on Marine Organism Immunomodulatory Activities.
    Montuori E; de Pascale D; Lauritano C
    Mar Drugs; 2022 Jun; 20(7):. PubMed ID: 35877715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel drugs from marine microorganisms.
    Javed F; Qadir MI; Janbaz KH; Ali M
    Crit Rev Microbiol; 2011 Aug; 37(3):245-9. PubMed ID: 21599497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential therapeutic agents from the red sea organisms.
    Alam MA
    Med Chem; 2014; 10(6):550-63. PubMed ID: 24364824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ten-Year Research Update Review: Antiviral Activities from Marine Organisms.
    Riccio G; Ruocco N; Mutalipassi M; Costantini M; Zupo V; Coppola D; de Pascale D; Lauritano C
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32645994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioactive Coumarins from Marine Sources: Origin, Structural Features and Pharmacological Properties.
    Vazquez-Rodriguez S; Matos MJ; Borges F; Uriarte E; Santana L
    Curr Top Med Chem; 2015; 15(17):1755-66. PubMed ID: 25915605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs.
    Ruiz-Torres V; Encinar JA; Herranz-López M; Pérez-Sánchez A; Galiano V; Barrajón-Catalán E; Micol V
    Molecules; 2017 Jun; 22(7):. PubMed ID: 28644406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marine natural products targeting phospholipases A2.
    Folmer F; Jaspars M; Schumacher M; Dicato M; Diederich M
    Biochem Pharmacol; 2010 Dec; 80(12):1793-800. PubMed ID: 20833149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor Potential of Immunomodulatory Natural Products.
    Nuzzo G; Senese G; Gallo C; Albiani F; Romano L; d'Ippolito G; Manzo E; Fontana A
    Mar Drugs; 2022 Jun; 20(6):. PubMed ID: 35736189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring marine resources for bioactive compounds.
    Kiuru P; DʼAuria MV; Muller CD; Tammela P; Vuorela H; Yli-Kauhaluoma J
    Planta Med; 2014 Sep; 80(14):1234-46. PubMed ID: 25203732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutically active secondary metabolites of marine actinobacteria.
    Manivasagan P; Venkatesan J; Sivakumar K; Kim SK
    Microbiol Res; 2014 Apr; 169(4):262-78. PubMed ID: 23958059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioactive marine drugs and marine biomaterials for brain diseases.
    Grosso C; Valentão P; Ferreres F; Andrade PB
    Mar Drugs; 2014 May; 12(5):2539-89. PubMed ID: 24798925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery pipelines for marine resources: an ocean of opportunity for biotechnology?
    Smith D; Buddie AG; Goss RJM; Overmann J; Lepleux C; Brönstrup M; Kloareg B; Meiners T; Brennecke P; Ianora A; Bouget FY; Gribbon P; Pina M
    World J Microbiol Biotechnol; 2019 Jul; 35(7):107. PubMed ID: 31267318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naturally occurring immunomodulators with antitumor activity: An insight on their mechanisms of action.
    Mohamed SIA; Jantan I; Haque MA
    Int Immunopharmacol; 2017 Sep; 50():291-304. PubMed ID: 28734166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marine Carbohydrate-Based Compounds with Medicinal Properties.
    Vasconcelos AA; Pomin VH
    Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 29987239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marine bacteria and fungi as promising source for new antibiotics.
    Wiese J; Imhoff JF
    Drug Dev Res; 2019 Feb; 80(1):24-27. PubMed ID: 30370576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effects of marine algal compounds in cosmeceuticals.
    Thomas NV; Kim SK
    Mar Drugs; 2013 Jan; 11(1):146-64. PubMed ID: 23344156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diversity, molecular mechanisms and structure-activity relationships of marine protease inhibitors-A review.
    Rauf A; Khalil AA; Olatunde A; Khan M; Anwar S; Alafnan A; Rengasamy KR
    Pharmacol Res; 2021 Apr; 166():105521. PubMed ID: 33662574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.